Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Administered Once Daily and Fluticasone Propionate Inhalation Powder 100mcg Twice Daily Compared With Placebo for 8 Weeks in Adolescent and Adult Subjects With Persistent Asthma Symptomatic on Non-Steroidal, Asthma Therapy
Brief Summary: This study is designed to determine if the investigational drug is effective and safe in individuals with asthma.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: GW685698X; Type: EXPERIMENTAL; Interventions: Drug: GW685698X | Intervention Type: DRUG; Name: GW685698X; Assigned to Arm(s): GW685698X | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
B: Arm Label: Subjects receiving fluticasone foroate/ vilanterol; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone foroate/ vilanterol, Drug: Fluticasone foroate, Drug: Vilanterol | Arm Label: Subjects receiving fluticasone foroate; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone foroate | Arm Label: Subjects receiving vilanterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Vilanterol | Arm Label: Subjects receiving placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Fluticasone foroate/ vilanterol; Assigned to Arm(s): Subjects receiving fluticasone foroate/ vilanterol | Intervention Type: DRUG; Name: Fluticasone foroate; Assigned to Arm(s): Subjects receiving fluticasone foroate, Subjects receiving fluticasone foroate/ vilanterol | Intervention Type: DRUG; Name: Vilanterol; Assigned to Arm(s): Subjects receiving fluticasone foroate/ vilanterol, Subjects receiving vilanterol | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Subjects receiving placebo
C: Arm Label: Fluticasone furoate/Vilanterol (GW642444); Type: EXPERIMENTAL; Interventions: Drug: Fluticasone furoate/Vilanterol Inhalation Powder, Drug: Placebo (2) | Arm Label: Fluticasone propionate/salmeterol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Fluticasone propionate/salmeterol Inhalation Powder, Drug: Placebo (1) | Intervention Type: DRUG; Name: Fluticasone furoate/Vilanterol Inhalation Powder; Assigned to Arm(s): Fluticasone furoate/Vilanterol (GW642444) | Intervention Type: DRUG; Name: Fluticasone propionate/salmeterol Inhalation Powder; Assigned to Arm(s): Fluticasone propionate/salmeterol | Intervention Type: DRUG; Name: Placebo (1); Assigned to Arm(s): Fluticasone propionate/salmeterol | Intervention Type: DRUG; Name: Placebo (2); Assigned to Arm(s): Fluticasone furoate/Vilanterol (GW642444)
D: Arm Label: Fluticasone furoate/GW642444; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone Furoate/GW642444 | Arm Label: fluticasone furoate; Type: EXPERIMENTAL; Interventions: Drug: Fluticasone furoate | Intervention Type: DRUG; Name: Fluticasone Furoate/GW642444; Assigned to Arm(s): Fluticasone furoate/GW642444 | Intervention Type: DRUG; Name: Fluticasone furoate; Assigned to Arm(s): fluticasone furoate

Answer: A